cosmetic semaglutide Microdose Treating 'Ozempic Face': Facial Rejuvenation
Description
Patients with type 2 diabetes who need better glucose control, weight loss, or cardiovascular protection may benefit from these therapies
Excess body weight increases glomerular pressure, promotes inflammation, and alters the kidney's handling of sodium and water
These factors support GLP-1 use in diabetes and obesity treatment
Over 84 weeks, the average weight loss was 25.5% with tirzepatide compared with 23.0% with CagriSema
